Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The amount reported in rows 6, 8, and 9 includes: (i) 16,424,204 shares of the Common Stock of Wealthfront Corporation (the "Issuer") directly beneficially owned by the Rachleff Family Revocable Trust UTD 5/19/92 (the "Family Trust"), for which Andrew S. Rachleff ("Mr. Rachleff") serves as co-trustee with his spouse; (ii) 403,225 shares of the Issuer's Common Stock directly beneficially owned by The Jake Alexander Rachleff 2015 Irrevocable Trust u/a/d 5/15/2015 (the "JAR Trust"), for which Mr. Rachleff serves as co-trustee with his spouse; and (iii) 403,225 shares of the Issuer's Common Stock directly beneficially owned by The Shelby Elizabeth Rachleff 2015 Irrevocable Trust u/a/d 5/15/2015 (the "SER Trust"), for which Mr. Rachleff serves as co-trustee with his spouse. The percentage set forth in row 11 was calculated in accordance with Rule 13(d)-3(d)(1)(i) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and based on an aggregate total of 146,268,749 shares of the Issuer's Common Stock outstanding as of December 15, 2025 as reported by the Issuer in its final prospectus supplement (the "Prospectus") (File No. 333-290583) dated December 11, 2025, filed with the Securities and Exchange Commission on December 12, 2025, pursuant to Rule 424(b)(4) promulgated under the Securities Act of 1933, as amended.


SCHEDULE 13G




Comment for Type of Reporting Person:  The amount reported in rows 6, 8, and 9 consists of 16,424,204 shares of the Issuer's Common Stock directly beneficially owned by the Family Trust, for which Mr. Rachleff serves as co-trustee with his spouse. The percentage set forth in row 11 was calculated in accordance with Rule 13(d)-3(d)(1)(i) promulgated under the Exchange Act, based on an aggregate total of 146,268,749 shares of the Issuer's Common Stock outstanding as of December 15, 2025 as reported by the Issuer in the Prospectus.


SCHEDULE 13G




Comment for Type of Reporting Person:  The amount reported in rows 6, 8, and 9 consists of 403,225 shares of the Issuer's Common Stock directly beneficially owned by the JAR Trust, for which Mr. Rachleff serves as co-trustee with his spouse. The percentage set forth in row 11 was calculated in accordance with Rule 13(d)-3(d)(1)(i) promulgated under the Exchange Act, based on an aggregate total of 146,268,749 shares of the Issuer's Common Stock outstanding as of December 15, 2025 as reported by the Issuer in the Prospectus.


SCHEDULE 13G




Comment for Type of Reporting Person:  The amount reported in rows 6, 8, and 9 consists of 403,225 shares of the Issuer's Common Stock directly beneficially owned by the SER Trust, for which Mr. Rachleff serves as co-trustee with his spouse. The percentage set forth in row 11 was calculated in accordance with Rule 13(d)-3(d)(1)(i) promulgated under the Exchange Act, based on an aggregate total of 146,268,749 shares of the Issuer's Common Stock outstanding as of December 15, 2025 as reported by the Issuer in the Prospectus.


SCHEDULE 13G



 
Andrew S Rachleff
 
Signature:/s/ Andrew S. Rachleff
Name/Title:Andrew S. Rachleff/ an Individual
Date:02/06/2026
 
Rachleff Family Revocable Trust UTD 5/19/92
 
Signature:/s/ Andrew S. Rachleff
Name/Title:Andrew S. Rachleff/ Co-Trustee
Date:02/06/2026
 
The Jake Alexander Rachleff 2015 Irrevocable Trust u/a/d 5/15/2015
 
Signature:/s/ Andrew S. Rachleff
Name/Title:Andrew S. Rachleff/ Co-Trustee
Date:02/06/2026
 
The Shelby Elizabeth Rachleff 2015 Irrevocable Trust u/a/d 5/15/2015
 
Signature:/s/ Andrew S. Rachleff
Name/Title:Andrew S. Rachleff/ Co-Trustee
Date:02/06/2026
Exhibit Information

Exhibit 99.1 Rachleff Joint Filing Agreement